Australia Cardiac Surgery Instruments Market Report 2022 to 2030

Australia Cardiac Surgery Instruments Market Analysis

$ 3999

The Australian Cardiac Surgery Instruments Market is expected to witness growth from $25 Mn in 2022 to $46 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Australia, the demand for minimally invasive surgical instruments, like endoscopes and laparoscopic instruments, is anticipated to increase in the Australian healthcare market as patients there seek out less invasive surgical choices that reduce scarring and recovery time. The market is segmented by type, application and by end user. Some key players in this market include Fairmont Medical Products, Rowe Medical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10AUMD004 CATEGORY: Medical Devices GEOGRAPHY: Australia AUTHOR: Jigyasu Bhandari

Buy Now

Australia Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Australia Cardiac Surgery Instruments Market size is at around $25 Mn in 2022 and is projected to reach $46 Mn in 2030, exhibiting a CAGR of 8.10% during the forecast period. Australia's expected total health expenditures for 2022-2023 is $105.8 billion, or 16.8% of all government spending in Australia. 10%, or about $105 billion in the fiscal year 2022, of Australia's economy, is accounted for by the health industry.

Cardiovascular disease is a major source of death and disability in Australia. 2.1 million Australians are thought to have cardiovascular disease, including 1.2 million people who have ischemic heart disease and 470,000 people who have experienced a stroke. The term acute coronary syndrome (ACS), which is used to characterize a number of conditions brought on by a sudden decrease in blood flow to the heart, was hospitalized 57,600 times in Australia in 2020. An incidence of 231 hospitalizations per 100,000 people can be calculated from this. The term "cardiac surgery instruments" refers to the specific tools and apparatus used by cardiac surgeons during various cardiac operations. Coronary artery bypass grafting (CABG), a type of cardiac surgery, is used to repair blocked or clogged coronary arteries. Coronary artery forceps, bypass grafting tools, and other cardiac surgery equipment are used in Spain to perform this operation. To repair damaged heart valves, a procedure known as valve replacement surgery is used. The tools used in cardiac surgery in Spain for this operation include valve retractors, valve dilators, and valve clamps. Aortic aneurysms are a condition that can cause the major blood vessel that carries blood from the heart to the rest of the body, the aorta, to enlarge and rupture. Aortic punches, vascular clamps, and aortic clamps are among the heart surgical instruments used in Spain to treat aortic aneurysms.

Australia Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

The Australian cardiac surgery instruments market is expected to see an increase in demand for minimally intrusive surgical tools like endoscopes and laparoscopic instruments as patients look for less invasive surgical options that shorten healing and scarring times. As a consequence of this trend, manufacturers in the Australian healthcare market are anticipated to experience growth. One of the measures the Australian government has taken to enhance the nation's healthcare infrastructure is increased funding for hospitals and healthcare providers. The demand for cardiac surgery equipment is likely to rise as healthcare institutions upgrade their technology. The leading cause of death in Australia is cardiovascular disease, and as the population matures, it is expected that these conditions will spread more widely. Instruments used in cardiac surgery, such as those for bypass surgery, valve replacement, and other procedures, are expected to see an increase in demand as a result.

Market Restraints

Australian and international manufacturers are competing for market share in the highly lucrative cardiac surgery instrument market in Australia. Manufacturers in Australia may find it challenging to stand out from competitors and keep their business profitable. There is a high demand in Australia for affordable healthcare goods and services because healthcare workers there are frequently cost-conscious. It might be difficult for manufacturers of tools for cardiac surgery to maintain high-profit margins as a consequence.

Competitive Landscape

Key Players

Fairmont Medical Products (AU)
Rowe Medical Supplies (AU)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

The Therapeutic Goods Administration (TGA) is the regulatory body in Australia in charge of guaranteeing the safety and efficacy of cardiac surgery devices. All medical devices, including those used in cardiac surgery, must be listed with the TGA prior to being made available throughout the Australian cardiac surgery devices market. Cardiac surgery instruments may undergo a single audit under the Medical Device Single Audit Program (MDSAP), which meets the criteria of regulatory agencies in several countries, including Australia. For manufacturers who sell their products in several countries, this simplifies the regulatory process. The Australian Register of Therapeutic Goods is a database that includes all medical equipment and therapeutic goods that are lawfully provided for sale in Australia. (ARTG).

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Australia market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.